We are live on ! Find out more
TLC

Taiwan Liposome Company, Ltd. American Depository Shares
TLC

Delisted

TLC was delisted on the 28th of September, 2021.

6 hedge funds and large institutions have $588K invested in Taiwan Liposome Company, Ltd. American Depository Shares in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

20% more funds holding

Funds holding: 56 (+1)

76% less capital invested

Capital invested by funds: $2.46M → $588K (-$1.87M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.12%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$4.9K
2
TRCT
Tower Research Capital (TRC)
New York
+$483

Top Sellers

Rank Fund Capital Flow
1
KPC
Karst Peak Capital
Hong Kong
-$2.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Millennium Management
1
Millennium Management
New York
$513K
Creative Planning
2
Creative Planning
Kansas
$61K
UBS Group
3
UBS Group
Switzerland
$6K +$4.9K +1,014 New
Osaic Holdings
4
Osaic Holdings
Arizona
$4K
HR
5
Howe & Rusling
New York
$3K
TRCT
6
Tower Research Capital (TRC)
New York
$1K +$483 +100 New
KPC
7
Karst Peak Capital
Hong Kong
-$2.1M -568,965 Closed

TLC Hedge Fund Activity: Q2 2020 in Review

6 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Taiwan Liposome Company, Ltd. American Depository Shares (TLC) for Q2 2020, worth a combined $588K — down 76% from $2.46M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TLC positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $4.9K. The largest seller was Karst Peak Capital, exiting entirely with an estimated $2.1M sold.

  • 6 institutional investors held Taiwan Liposome Company, Ltd. American Depository Shares (TLC) as of Q2 2020, up from 5 in Q1 2020.
  • Funds reported $588K of Taiwan Liposome Company, Ltd. American Depository Shares stock for Q2 2020, down 76% quarter-over-quarter.
  • 2 funds opened new Taiwan Liposome Company, Ltd. American Depository Shares positions in Q2 2020 and 1 closed out, a net change of +1 holder.
  • The largest Taiwan Liposome Company, Ltd. American Depository Shares buyer in Q2 2020 was UBS Group, an estimated $4.9K added.
  • The largest Taiwan Liposome Company, Ltd. American Depository Shares seller in Q2 2020 was Karst Peak Capital, an estimated $2.1M sold.

Based on aggregated 13F filings for Q2 2020.